Engeland Anders, Bramness Jørgen G, Daltveit Anne Kjersti, Rønning Marit, Skurtveit Svetlana, Furu Kari
Department of Pharmacoepidemiology, Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway.
Br J Clin Pharmacol. 2008 May;65(5):653-60. doi: 10.1111/j.1365-2125.2008.03102.x. Epub 2008 Feb 20.
Mothers are using medicines during pregnancies; the extent varies across the world and is generally difficult to compare. In this registry-based study, we examined more than 100,000 Norwegian pregnancies and described the drug prescription pattern of both fathers and mothers around conception and during pregnancy (mothers).
In every trimester of pregnancy, about 30% of the mothers was dispensed a drug. The total drug exposure did not seem to diminish throughout pregnancy. One-quarter of the fathers was dispensed drugs during the last 3 months prior to conception.
The primary aim of this study was to describe the use of prescribed drugs in both mothers and fathers before and during pregnancy in Norway.
This population-based cohort study was based on data retrieved from the Medical Birth Registry of Norway and the Norwegian Prescription Database. These registries cover the entire population of Norway. Information on >100,000 births during 2004-2006 in the birth registry was linked to prescription data. Prescriptions issued to mothers just prior to, during and after the pregnancies as well as prescriptions to fathers just prior to conception were identified.
Among mothers, 83% were prescribed drugs during the period 3 months prior to estimated conception until 3 months after giving birth. The mothers who received drugs were prescribed on average 3.3 different Anatomical Therapeutic Chemical (ATC) codes (range 1-38). During pregnancy, 57% were prescribed drugs. In the first trimester, 33% of mothers were dispensed drugs, while the figure was 29% for mothers in the last trimester. Among fathers, 25% used prescribed drugs during the 3 months prior to conception, with on average 1.9 different ATC codes (range 1-22).
Large proportions of both fathers and mothers were dispensed drugs prior to conception or during pregnancy. While there is a high awareness of the issues involved in maternal drug use in pregnancy, possible teratogenic effects of drug use in fathers shortly before conception should be further explored.
母亲在孕期会使用药物;其使用程度在世界各地有所不同,且通常难以进行比较。在这项基于登记处的研究中,我们调查了超过10万例挪威孕妇,并描述了父母双方在受孕前后及孕期(母亲)的药物处方模式。
在孕期的每个阶段,约30%的母亲会被配药。整个孕期的药物总暴露量似乎并未减少。四分之一的父亲在受孕前的最后3个月内会被配药。
本研究的主要目的是描述挪威父母在怀孕前后使用处方药的情况。
这项基于人群的队列研究基于从挪威医疗出生登记处和挪威处方数据库中检索到的数据。这些登记处覆盖了挪威的全部人口。出生登记处中2004 - 2006年期间超过10万例出生的信息与处方数据相关联。确定了在怀孕前、孕期及产后给母亲开具的处方以及受孕前给父亲开具的处方。
在母亲中,83%在预计受孕前3个月至产后3个月期间被开具了药物。接受药物治疗的母亲平均被开具3.3种不同的解剖治疗化学(ATC)编码(范围为1 - 38)。在孕期,57%的母亲被开具了药物。在孕早期,33%的母亲被配药,而在孕晚期这一比例为29%。在父亲中,25%在受孕前3个月内使用了处方药,平均有1.9种不同的ATC编码(范围为1 - 22)。
很大比例的父母在受孕前或孕期被配药。虽然人们对孕期母亲用药所涉及的问题有较高认识,但受孕前不久父亲用药可能产生致畸作用这一问题仍有待进一步探究。